Net Income

Following a $47.5M funding round, CertifID is bolstering its leadership to fight a new wave of sophisticated, AI-driven wire fraud in real estate.

China's EdTech giant TAL is set to report Q4 earnings. Investors are watching closely to see if its pivot to AI and smart devices is a winning strategy.

Appliance giant Electrolux is set to release its Q1 results. Investors are watching to see if cost-cutting can overcome weak consumer demand.

Whitestone REIT holds its dividend steady, backed by record occupancy, strong financials, and a unique strategy in high-growth Sun Belt markets.

The ONEflight Myrtle Beach Classic blends PGA TOUR golf with F1 speed, Hollywood stars, and a Beach Boys concert, redefining the luxury sports experience.

A new nonprofit is using crypto transaction fees to fight childhood hunger, partnering with Feed the Children in a bold new experiment for philanthropy.

Following a massive stock surge, Forte Biosciences is raising $150M. The funds are crucial for a pivotal year of clinical trials for its autoimmune drug.

The retailer posts modest annual growth despite a tough Q4, as international gains and efficiency drives offset major headwinds in its Canadian operations.

With its lead drug in Phase 3 and a strong Biogen partnership, Stoke Therapeutics prepares to update investors on its disease-modifying Dravet syndrome therapy.

ADP's latest dividend declaration highlights its financial strength and commitment to shareholders, cementing its status as a reliable income-generating stock.

A single-dose therapy wiped out aggressive glioblastoma tumors in a landmark pre-clinical study, paving the way for human trials in 2026.

As AI and automation reshape global tax, a new online certificate from IBFD and VU Amsterdam aims to equip professionals with crucial, future-proof skills.

A new report reveals a massive security blind spot. Unmanaged apps, fueled by AI adoption, are causing data breaches, audit failures, and huge financial losses.

With most OUD patients lacking access to care, a new grant funds research into payment models that reward results, not just services.

The energy tech giant completes its EMEA business divestiture to AURELIUS, sharpening focus on the Americas and APAC while reshaping Europe's grid market.

A new clinical trial is underway for a next-gen aortic valve, promising a less invasive procedure and improved durability for millions of patients.

After a multi-year legal battle over a construction project ended in a total loss, Colleyville taxpayers are footing a $1.37 million bill.

The nation's top farm co-op faces mounting losses from biofuel rules and weak grain markets, signaling wider distress across the American heartland.

Galloway Capital Partners takes a 5.44% stake in Chegg, arguing the ed-tech firm is undervalued and a strategic split could revive its fortunes.

Absci will showcase its generative AI drug discovery platform at a key healthcare conference, highlighting its ambitious pipeline for hair loss and endometriosis.